Navigation Links
The Economist's Pharma Summit 2013: 'Back to Basics - the Real Business of Pharma'
Date:1/29/2013

LONDON, January 29, 2013 /PRNewswire/ --

~ Tweet your questions ahead of The Pharma Summit 2013 at @EG_Healthcare ~

Should Pharma cut its losses and get out of R&D, or does it still have a role to play in medical research?

The Economist Events is holding its 19th Annual Pharma Summit 2013 in London on Thursday, 28th February 2013. The summit will be held at The Dorchester Hotel,  Park Lane London, W1K 1QA from 8:30am to 5:00pm.

The Pharma Summit has become an established key global event for the healthcare industry, attracting and gathering some of the most influential names in the global pharmaceutical and healthcare industries. This year's theme 'Back to basics -the real business of Pharma' will assess the challenges the industry is facing as the last remaining blockbuster drugs reach the end of their patent protection.

"This year's conference theme is particularly pertinent." said Edwin Moses , a panel speaker and the CEO of Ablynx. "We have to start looking beyond the patent cliff when assessing the health of the Pharma industry, especially in light of tight healthcare budgets and R&D productivity. The Pharma Summit brings together some of the industry's leading experts who have a unique insight into these issues and the significant trends in the space at the moment."

The event will focus on a number of topical issues, such as the change in Big Pharma business models post-blockbuster, the shifts in the drug discovery and development paradigm, and Pharma in an age of austerity, explored through a series of thought provoking keynotes, panel discussions, interviews and debates.

Join us on Twitter @EG_Healthcare to get the latest updates on The Pharma Summit, submit your questions, and join in with discussions on the day.

Among others, you will hear from:  

  • Severin Schwan , Chief Executive Officer, Roche Group
  • Klaus Wilgenbus, Corporate Senior Vice-president, Boehringer Ingelheim
  • Edwin Moses , Chief Executive Officer, Ablynx
  • Anders Gersel Pedersen , Executive Vice-president, Drug Development, Lundbeck
  • Jane Griffiths , Company Group Chairman, Janssen Europe , Middle East and Africa, Johnson & Johnson
  • Nigel Clerkin, Executive Vice-president and Chief Financial Officer, Elan Corporation plc
  • Kate Bingham , Managing Partner, SV Life Sciences Advisers LLP
  • Paul Stoffels , Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson
  • Roch Doliveux, Chief Executive Officer and Chairman of the Executive Committee, UCB

For more information and to view the full programme please visit: http://www.thepharmasummit.com  

About The Economist Events

The Economist Events is part of the Management Thinking division of The Economist Group. Our philosophy is to tackle issues with a forward-looking, uniquely global perspective. We create events that are for the intellectually curious: those people who enjoy ideas and those who are passionate about the issues that define our world.

This press release has been issued by M:Communications on behalf of The Economist Events' The Pharma Summit 2013.

Contact Information:

For further information on event registration or to request interviews with any of the speakers at The Pharma Summit 2013, please contact Amber Bielecka , Hollie Vile or Claire Dickinson within the official press office:

M:Communications, official press office for The Economist Healthcare Events

E: pharmasummit2013@mcomgroup.com

Tel: +44-(0)20-7920-2360


'/>"/>
SOURCE The Economist’s Pharma Summit
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Actinium Pharmaceuticals to Present at EMIT Targeted Radiotherapy Conference
2. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
3. CPhI Southeast Asia Broadens Focus to Highlight Vibrant ASEAN Pharma Market
4. Study Delivers Investment Benchmarks across Key New Product Launch Activities in Pharmaceutical Sector
5. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
6. Drugstore Lobby Poll of Seniors: Mail-Service Pharmacies Cost Less than Community Drugstores
7. Metabolic Solutions Development Company announces publication of Phase 2b data in Clinical Pharmacology & Therapeutics
8. Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.
9. The Leukemia & Lymphoma Society and Avella Specialty Pharmacy to Present Free Event on Oral Chemotherapy Drugs
10. Harwood Feffer LLP Announces Investigation of MAP Pharmaceuticals, Inc.
11. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the Cowen and Company 37 th ... Copley Place on Tuesday, March 7, 2017 at 11:20 ... of the presentation can be accessed at http://wsw.com/webcast/cowen38/zbh ... the conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/24/2017)... Research and Markets has announced the addition of the "Hemophilia Drugs ... ... Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks ... What are the key drugs marketed for ... Hemophilia market? What are the unit prices and annual ...
(Date:2/24/2017)... HARRISBURG, Pa. , Feb. 24, 2017 ... Secretary of Drug and Alcohol Programs Jennifer Smith ... role in providing training for and using naloxone, a ... Mark McCullough , a recovery specialist and overdose ... naloxone by EMS providers. "A significant part ...
Breaking Medicine Technology:
(Date:2/24/2017)... , ... February 24, 2017 , ... Yisrayl Hawkins, Pastor ... on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement when ... generation. He explains that the Bible details the current times so plainly that ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to the La Gorce Country Club in Miami Beach to host its Swirl: ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
Breaking Medicine News(10 mins):